← FDA Drug Approvals (Drugs@FDA)
DIAZEPAM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: REGCON HOLDINGS · Approved 2019-03-18
Drug application
- FDA Application #
ANDA210363- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DIAZEPAM
- Generic name
- DIAZEPAM
- Active ingredients
- DIAZEPAM
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- REGCON HOLDINGS
- Manufacturer
- Natco Pharma USA LLC
- First approval
- 2019-03-18
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown